Syros to Participate in Upcoming Investor Conferences
November 21 2023 - 6:30AM
Business Wire
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company
committed to advancing new standards of care for the frontline
treatment of hematologic malignancies, today announced that company
management will participate in a fireside chat at two upcoming
investor conferences. Management will also be available for
one-on-one meetings. Details are as follows:
Piper Sandler 35th Annual Healthcare Conference Date:
Tuesday, November 28 Presentation Time: 2:00 p.m. ET Location: The
Lotte New York Palace, 455 Madison Ave, New York, NY
JMP Securities Hematology and Oncology Summit Date:
Wednesday, December 6 Presentation Time: 11:00 a.m. ET Location:
Virtual
To access the webcasts and subsequent archived recording of each
event, please visit the Investors & Media section of the Syros
website at www.syros.com. An archived replay of each webcast will
be available for approximately 30 days following each
presentation.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the
frontline treatment of patients with hematologic malignancies.
Driven by the motivation to help patients with blood disorders that
have largely eluded other targeted approaches, Syros is developing
tamibarotene, an oral selective RARα agonist in frontline patients
with higher-risk myelodysplastic syndrome and acute myeloid
leukemia with RARA gene overexpression. For more information, visit
www.syros.com and follow us on Twitter (@SyrosPharma) and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231121742692/en/
Syros Contact Karen Hunady Director of Corporate
Communications & Investor Relations 1-857-327-7321
khunady@syros.com
Investor Contact Hannah Deresiewicz Stern Investor
Relations, Inc. 212-362-1200 hannah.deresiewicz@sternir.com
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From May 2024 to Jun 2024
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Jun 2023 to Jun 2024